Sat June 11, 2022
Science at Cal – Laboratory to Life-Saver: Discovery, Development, and Access to New Medicines
SEE EVENT DETAILS
at Valley Life Sciences Building, Room 2050
(see times)
How are new medicines discovered and developed? How can universities help create products that truly benefit patients? How do the government and private companies decide which projects to invest in? Drug discovery often follows a long, rocky and winding road to success. In this talk, Dr. Schaletzky, the Executive Director of Berkeley's Center for Emerging and Neglected Diseases, will highlight some innovative campaigns resulting in first-in-class therapies for patients with heart failure, cancer, and infectious diseases. A scientist who spans many fields of research, Dr. Schaletzky will provide an overview of translational science, the drug discovery and development process, and how the academic and private sectors can work together more productively. She will also touch on access to medicines, affordability, the power of monopolies, and how to continue to create solutions even without an economic incentive.
A note about this in-person event:
This is an in-person event. In order to maintain capacity limits, registration will be required through Eventbrite. Please bring a copy of your ticket to the event, either on your mobile device or printed out. Science at Cal will follow any and all University and City of Berkeley COVID-19 guidelines at the time of the event. We remind you that wearing a mask indoors is strongly recommended by the campus and the city public health officer. Please see UC Berkeley's current mask guidance here.
About our Speaker:
Dr. Julia Schaletzky
Executive Director
Center for Emerging and Neglected Diseases
Dr. Julia Schaletzky is an interdisciplinary biomedical scientist and entrepreneur active both in the private sector and in academia. She is the Executive Director of the Center for Emerging and Neglected Diseases at the University of California, Berkeley, as well as of the Drug Discovery Center and Immunotherapy and Vaccine Research Initiative. After studying biochemistry in her native Germany, she moved to Harvard Medical School for graduate school. Interested in applied science, Dr. Schaletzky joined a biotechnology company, Cytokinetics, to develop new therapies for heart disease and neurodegenerative disorders, with several molecules in late-stage clinical trials. In her role at UC Berkeley, she focuses on interdisciplinary approaches and public/private partnership for the discovery and development of new therapies and tools, particularly for unmet medical needs. Dr. Schaletzky is also is a lecturer at the Haas School of Business, teaching Bioentrepreneurship, Access to Medicines and Drug Development for Neglected Diseases. She has received NIH-funded grants to support underrepresented minorities and women in STEM in the U.S. and runs a program in Uganda to build local research capacity. Dr. Schaletzky is broadly interested in global public health, health equity, and the governance of processes that end up influencing who gets care and who does not.
show less
A note about this in-person event:
This is an in-person event. In order to maintain capacity limits, registration will be required through Eventbrite. Please bring a copy of your ticket to the event, either on your mobile device or printed out. Science at Cal will follow any and all University and City of Berkeley COVID-19 guidelines at the time of the event. We remind you that wearing a mask indoors is strongly recommended by the campus and the city public health officer. Please see UC Berkeley's current mask guidance here.
About our Speaker:
Dr. Julia Schaletzky
Executive Director
Center for Emerging and Neglected Diseases
Dr. Julia Schaletzky is an interdisciplinary biomedical scientist and entrepreneur active both in the private sector and in academia. She is the Executive Director of the Center for Emerging and Neglected Diseases at the University of California, Berkeley, as well as of the Drug Discovery Center and Immunotherapy and Vaccine Research Initiative. After studying biochemistry in her native Germany, she moved to Harvard Medical School for graduate school. Interested in applied science, Dr. Schaletzky joined a biotechnology company, Cytokinetics, to develop new therapies for heart disease and neurodegenerative disorders, with several molecules in late-stage clinical trials. In her role at UC Berkeley, she focuses on interdisciplinary approaches and public/private partnership for the discovery and development of new therapies and tools, particularly for unmet medical needs. Dr. Schaletzky is also is a lecturer at the Haas School of Business, teaching Bioentrepreneurship, Access to Medicines and Drug Development for Neglected Diseases. She has received NIH-funded grants to support underrepresented minorities and women in STEM in the U.S. and runs a program in Uganda to build local research capacity. Dr. Schaletzky is broadly interested in global public health, health equity, and the governance of processes that end up influencing who gets care and who does not.
How are new medicines discovered and developed? How can universities help create products that truly benefit patients? How do the government and private companies decide which projects to invest in? Drug discovery often follows a long, rocky and winding road to success. In this talk, Dr. Schaletzky, the Executive Director of Berkeley's Center for Emerging and Neglected Diseases, will highlight some innovative campaigns resulting in first-in-class therapies for patients with heart failure, cancer, and infectious diseases. A scientist who spans many fields of research, Dr. Schaletzky will provide an overview of translational science, the drug discovery and development process, and how the academic and private sectors can work together more productively. She will also touch on access to medicines, affordability, the power of monopolies, and how to continue to create solutions even without an economic incentive.
A note about this in-person event:
This is an in-person event. In order to maintain capacity limits, registration will be required through Eventbrite. Please bring a copy of your ticket to the event, either on your mobile device or printed out. Science at Cal will follow any and all University and City of Berkeley COVID-19 guidelines at the time of the event. We remind you that wearing a mask indoors is strongly recommended by the campus and the city public health officer. Please see UC Berkeley's current mask guidance here.
About our Speaker:
Dr. Julia Schaletzky
Executive Director
Center for Emerging and Neglected Diseases
Dr. Julia Schaletzky is an interdisciplinary biomedical scientist and entrepreneur active both in the private sector and in academia. She is the Executive Director of the Center for Emerging and Neglected Diseases at the University of California, Berkeley, as well as of the Drug Discovery Center and Immunotherapy and Vaccine Research Initiative. After studying biochemistry in her native Germany, she moved to Harvard Medical School for graduate school. Interested in applied science, Dr. Schaletzky joined a biotechnology company, Cytokinetics, to develop new therapies for heart disease and neurodegenerative disorders, with several molecules in late-stage clinical trials. In her role at UC Berkeley, she focuses on interdisciplinary approaches and public/private partnership for the discovery and development of new therapies and tools, particularly for unmet medical needs. Dr. Schaletzky is also is a lecturer at the Haas School of Business, teaching Bioentrepreneurship, Access to Medicines and Drug Development for Neglected Diseases. She has received NIH-funded grants to support underrepresented minorities and women in STEM in the U.S. and runs a program in Uganda to build local research capacity. Dr. Schaletzky is broadly interested in global public health, health equity, and the governance of processes that end up influencing who gets care and who does not.
read more
A note about this in-person event:
This is an in-person event. In order to maintain capacity limits, registration will be required through Eventbrite. Please bring a copy of your ticket to the event, either on your mobile device or printed out. Science at Cal will follow any and all University and City of Berkeley COVID-19 guidelines at the time of the event. We remind you that wearing a mask indoors is strongly recommended by the campus and the city public health officer. Please see UC Berkeley's current mask guidance here.
About our Speaker:
Dr. Julia Schaletzky
Executive Director
Center for Emerging and Neglected Diseases
Dr. Julia Schaletzky is an interdisciplinary biomedical scientist and entrepreneur active both in the private sector and in academia. She is the Executive Director of the Center for Emerging and Neglected Diseases at the University of California, Berkeley, as well as of the Drug Discovery Center and Immunotherapy and Vaccine Research Initiative. After studying biochemistry in her native Germany, she moved to Harvard Medical School for graduate school. Interested in applied science, Dr. Schaletzky joined a biotechnology company, Cytokinetics, to develop new therapies for heart disease and neurodegenerative disorders, with several molecules in late-stage clinical trials. In her role at UC Berkeley, she focuses on interdisciplinary approaches and public/private partnership for the discovery and development of new therapies and tools, particularly for unmet medical needs. Dr. Schaletzky is also is a lecturer at the Haas School of Business, teaching Bioentrepreneurship, Access to Medicines and Drug Development for Neglected Diseases. She has received NIH-funded grants to support underrepresented minorities and women in STEM in the U.S. and runs a program in Uganda to build local research capacity. Dr. Schaletzky is broadly interested in global public health, health equity, and the governance of processes that end up influencing who gets care and who does not.
show less
Date/Times:
Valley Life Sciences Building, Room 2050
Harmon Way, Berkeley, CA 94720
The Best Events
Every Week in Your Inbox
From Our Sponsors
UPCOMING EVENTS
Great suggestion! We'll be in touch.
Event reviewed successfully.